April 30, 2020 - A national decision-making process should be established as soon as possible to review ongoing research here and abroad and provide advice to Canadian governments, according to the C.D. Howe Institute’s Crisis Working Group on Public Health and Emergency Measures. Unprecedented collaboration will be required if a coronavirus vaccine is to be approved and available to the public within an 18-month timeframe.
Canada should leverage its existing advantage in vaccine manufacturing and begin expanding domestic capacity to ensure access for Canadians and the potential to contribute to the global supply through exports. Next steps include:
- Establishing the process for evaluating successful trials.
- Determine the Criteria for selecting vaccines for Canadian market approval.
- Immediate expansion of domestic manufacturing capacity.
For more information, please contact: Rosalie Wyonch, Policy Analyst, C.D. Howe Institute; Laura Bouchard, Communications Manager, C.D. Howe Institute: Phone: 416 865-9935.